Ping An Biomedical Files $300M Shelf Days After 1-for-40 Reverse Split
PASW sits 39% above its 52-week low of $3.07.
Summary
Ping An Biomedical registered a $300 million universal shelf on Form F-3 the same day as its 1-for-40 reverse split. The filing is authorization only — no securities have been sold — and the tiny non-affiliate float means actual annual raises are capped at a fraction of the headline amount.
Key Events · Financing and Capital Events · PASW
-
Universal Shelf Registered
Form F-3 covers up to $300,000,000 of Class A ordinary shares, debt securities, warrants, share purchase contracts, share purchase units, units and rights, to be sold from time to time after the registration becomes effective.
-
Practical Raise Capped by Tiny Float
Non-affiliate Class A shares were worth approximately $6,851,487 on October 8, 2026 (59.63 million shares at $0.1149), so General Instruction I.B.5 limits primary sales to one-third of that float in any 12-month period — a few million dollars, not $300 million.
-
Registration Fee $26,100
The filing fee was calculated under Rule 457(o) on the $300,000,000 maximum aggregate offering price at a 0.0087% rate.
-
Delisting Overhang Persists
The prospectus restates the November 24, 2025 Nasdaq minimum bid price deficiency notice and warns that a close at $0.10 or less for 10 consecutive trading days triggers immediate suspension and delisting with no cure period.
Analysis · PASW · Manufacturing
The $300 million headline is a ceiling, not a raise. Because non-affiliates hold only about $6.85 million of Class A shares, General Instruction I.B.5 caps what the company can actually sell in any 12-month window at roughly one-third of that float — a few million dollars, not $300 million. That matters because the company is already fighting a Nasdaq minimum bid price deficiency and just executed a 1-for-40 reverse split on the same day this shelf was filed. A shelf registration is permission to sell securities later, not a sale: no shares have been issued and no proceeds have been received. The real story is that a micro-cap with a thin public float and a delisting overhang has now put a standing dilution mechanism in place, and any takedown will hit a shareholder base that is roughly 91.56% controlled by Pijun Liu.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 29.2% of the 1549 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PASW was trading at $4.28 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $670.6M. The 52-week trading range was $3.07 to $32.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.